Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Dec;41(6):587–592. doi: 10.1136/ard.41.6.587

Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis.

M Ravid, J Shapira, R Lang, I Kedar
PMCID: PMC1000989  PMID: 7149795

Abstract

Continuous oral dimethylsulphoxide (DMSO) treatment (7-15 g/day) was given to 3 patients with amyloidosis of familial Mediterranean fever (FMF), 3 patients with idiopathic amyloidosis, and 7 patients with secondary amyloidosis. The nephrotic syndrome and various degrees of renal insufficiency were the major clinical manifestation in all case. Renal function was used as the main parameter for evaluation of therapy. DMSO treatment for 7-16 months produced no effect in the FMF patients and in the patient with idiopathic amyloidosis; they all ran the predictable clinical course of their disease and either died of cardiac failure or have been maintained on chronic haemodialysis. In the 7 patients with secondary amyloidosis an unequivocal improvement of renal function was observed following 3-6 months of DMSO treatment. It was shown by a 30-100% rise of creatinine clearance and a decline in proteinuria. This new equilibrium has been maintained as long as DMSO was administered. No serious side effects of DMSO wee encountered. Mild nausea and an unpleasant breath odour were the patients' main concern. We conclude that a therapeutic trial with oral DMSO is warranted in all patients with secondary amyloidosis. This treatment is unpleasant but bears no exceptional risks. It may significantly prolong life, though its effect on amyloid deposits themselves is doubtful.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buxbaum J. N., Hurley M. E., Chuba J., Spiro T. Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisone. Am J Med. 1979 Nov;67(5):867–878. doi: 10.1016/0002-9343(79)90747-2. [DOI] [PubMed] [Google Scholar]
  2. Glenner G. G. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980 Jun 12;302(24):1333–1343. doi: 10.1056/NEJM198006123022403. [DOI] [PubMed] [Google Scholar]
  3. Hanai N., Ishihara T., Uchino F., Imada N., Fujihara S., Ikegami J. Effects of dimethyl sulfoxide and colchicine on the resorption of experimental amyloid. Virchows Arch A Pathol Anat Histol. 1979;384(1):45–52. doi: 10.1007/BF00427150. [DOI] [PubMed] [Google Scholar]
  4. Kedar I., Greenwald M., Ravid M. Treatment of experimental murine amyloidosis with dimethyl sulfoxide. Eur J Clin Invest. 1977 Apr;7(2):149–150. doi: 10.1111/j.1365-2362.1977.tb01589.x. [DOI] [PubMed] [Google Scholar]
  5. Kyle R. A., Bayrd E. D. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975 Jul;54(4):271–299. doi: 10.1097/00005792-197507000-00001. [DOI] [PubMed] [Google Scholar]
  6. Levin M., Franklin E. C., Frangione B., Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest. 1972 Oct;51(10):2773–2776. doi: 10.1172/JCI107098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mackensen S., Grund K. E., Bader R., Bohle A. The influence of glomerular and interstitial factors on the serum creatinine concentration in renal amyloidosis. Virchows Arch A Pathol Anat Histol. 1977 Sep 28;375(3):159–168. doi: 10.1007/BF01102985. [DOI] [PubMed] [Google Scholar]
  8. Ravid M., Keizman I. K., Sohar E. Effect of a single dose of dimethyl sulphoxide on renal amyloidosis. Lancet. 1977 Apr 2;1(8014):730–731. doi: 10.1016/s0140-6736(77)92171-7. [DOI] [PubMed] [Google Scholar]
  9. Ravid M., Robson M., Kedar I. Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med. 1977 Nov;87(5):568–570. doi: 10.7326/0003-4819-87-5-568. [DOI] [PubMed] [Google Scholar]
  10. Wright J. R., Calkins E., Humphrey R. L. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest. 1977 Mar;36(3):274–281. [PubMed] [Google Scholar]
  11. Yellowlees P., Greenfield C., McIntyre N. Dimethylsulphoxide-induced toxicity. Lancet. 1980 Nov 8;2(8202):1004–1006. doi: 10.1016/s0140-6736(80)92158-3. [DOI] [PubMed] [Google Scholar]
  12. von Gise H., Helmchen U., Mikeler E., Brüning L., Walther C., Christ H., Mackensen S., Bohle A. Correlations between the morphological and clinical findings in a patient recovering from secondary generalised amyloidosis with renal involvement. Light- and electron microscopic investigations on serial biopsies. Virchows Arch A Pathol Anat Histol. 1978 Aug 22;379(2):119–129. doi: 10.1007/BF00432481. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES